Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05444699 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Oral Prednisolone for Acute Rhinovirus Induced Wheezing in Children Less Than 2 Years of Age

Study acronym: RhinoPOCRCT
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Sep 2025 to Dec 2026v6
  2. Site contacts updated at 1 of 2 sitesv5
  3. Study sites: 1 to 2v4
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 2022 to Oct 11, 2022
    • Site details revised
    v3
  5. Primary completion date: Feb 2024 to Sep 2025v2 Show 7 more changesShow less
    • Primary endpoint revised
    • Study completion date: Feb 2026 to Sep 2027
    • Interventions: ORA-Plus-/ORA-Sweet-mixture (Drug), Prednisolone Sodium Phosphate (Drug) to Prednisolone Sodium Phosphate (Drug), Sugar syrup (Drug)
    • Secondary endpoints revised (16)
    • Study description shortened, about 107 words
    • Eligibility criteria expanded, about 2 words
    • Study title expanded, about 2 words
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of the trial is to evaluate whether the use of oral prednisolone directed by point-of-care testing is useful in acute wheezing caused by rhinovirus in children aged 6-24 months.
Trial Details
NCT Number NCT05444699
Lead Sponsor University of Oulu
Conditions
(from sponsor)		 Bronchiolitis Acute Viral
Enrollment 210 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov